These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 210295)

  • 1. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus.
    Minden P; McClatchy JK; Brunda MJ
    J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of growth of guinea pig line-10 hepatocarcinoma. I. Effect of simultaneous administration of tumor cells and antibodies from normal rabbits.
    Brunda MJ; Minden P; Heusser CH; Ferguson HR
    J Immunol; 1978 Mar; 120(3):831-6. PubMed ID: 75927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
    Schlager SI; Dray S
    Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
    Schlager SI; Paque RE; Dray S
    Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of antigen by intralymphatic route in the rat. II. Results in tumor active immunotherapy (delta). Preliminary report.
    Sulis E; Busilacchi M; Turno R; Monni A; Chessa A; Zizi P; Pani P; Manconi PE
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):252-4. PubMed ID: 189786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete local tumor regression with antibody to fibrin Fragment E.
    Schlager SI; Dray S
    J Immunol; 1975 Oct; 115(4):976-81. PubMed ID: 170340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of tumor rejection by trypan blue.
    Kreider JW; Bartlett GL; DeFreitas E
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunogenicity of line 10 guinea pig hepatocarcinoma cells after culture.
    Correll LL; Nielsen LD; Kelleher PJ; Harbell JW; Minden P
    J Natl Cancer Inst; 1983 Dec; 71(6):1343-6. PubMed ID: 6581367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG.
    McCoy JL; Brandhorst J; Hanna MG
    J Natl Cancer Inst; 1978 Mar; 60(3):693-9. PubMed ID: 75270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of transplanted rat tumors following administration of cell-free tumor antigens.
    Tracey RS; Wepsic HT; Alaimo J; Morris HP
    Cancer Res; 1978 May; 38(5):1208-12. PubMed ID: 205357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
    Minden P; Mathews HL; Kelleher PJ
    J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.